Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Alonso

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 14, 2009
Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistryAlejandra M Scursoni, Laura Galluzzo, Sandra Camarero, et al.
Translational Lung Cancer Research|October 24, 2025
Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancerValeria I Segatori, Selene Rojo, Cynthia A Gulino, et al.
Cancer Research|October 7, 2004
Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)Silvio E Perea, Osvaldo Reyes, Yaquelin Puchades, et al.
Pediatric Blood & Cancer|July 9, 2015
A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory MalignanciesWalter Cacciavillano, Claudia Sampor, Cecilia Venier, et al.
Oncotarget|October 23, 2018
Aberrant O-glycosylation modulates aggressiveness in neuroblastomaHector A Cuello, Valeria I Segatori, Marina Albertó, et al.
Pharmaceutics|March 28, 2026
In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human OsteosarcomaLucía Santa Maria de la Parra, Matías H Assandri, Luisina M Solernó, et al.
Molecular Medicine Reports|April 17, 2014
Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cellsMaría B Pastrian, Fanny Guzmán, Juan Garona, et al.
International Journal of Oncology|April 8, 2015
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer modelsJuan Garona, Marina Pifano, Ulises D Orlando, et al.
JAMA Ophthalmology|May 1, 2015
Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic RetinoblastomaAna V Torbidoni, Viviana E Laurent, Claudia Sampor, et al.
International Journal of Cancer|September 12, 2007
Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in miceYasser Perera, Hernán G Farina, Ignacio Hernández, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 14, 2009
Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistryAlejandra M Scursoni, Laura Galluzzo, Sandra Camarero, et al.
Translational Lung Cancer Research|October 24, 2025
Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancerValeria I Segatori, Selene Rojo, Cynthia A Gulino, et al.
Cancer Research|October 7, 2004
Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)Silvio E Perea, Osvaldo Reyes, Yaquelin Puchades, et al.
Pediatric Blood & Cancer|July 9, 2015
A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory MalignanciesWalter Cacciavillano, Claudia Sampor, Cecilia Venier, et al.
Oncotarget|October 23, 2018
Aberrant O-glycosylation modulates aggressiveness in neuroblastomaHector A Cuello, Valeria I Segatori, Marina Albertó, et al.
Pharmaceutics|March 28, 2026
In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human OsteosarcomaLucía Santa Maria de la Parra, Matías H Assandri, Luisina M Solernó, et al.
Molecular Medicine Reports|April 17, 2014
Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cellsMaría B Pastrian, Fanny Guzmán, Juan Garona, et al.
International Journal of Oncology|April 8, 2015
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer modelsJuan Garona, Marina Pifano, Ulises D Orlando, et al.
JAMA Ophthalmology|May 1, 2015
Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic RetinoblastomaAna V Torbidoni, Viviana E Laurent, Claudia Sampor, et al.
International Journal of Cancer|September 12, 2007
Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in miceYasser Perera, Hernán G Farina, Ignacio Hernández, et al.
Pageof 10